Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Evercore ISI Group analyst Elizabeth Anderson maintains Health Catalyst (NASDAQ:HCAT) with a In-Line and lowers the price ta...
Keybanc analyst Scott Schoenhaus maintains Health Catalyst (NASDAQ:HCAT) with a Overweight and lowers the price target from ...
Cantor Fitzgerald analyst Sarah James reiterates Health Catalyst (NASDAQ:HCAT) with a Neutral and maintains $4 price target.
BTIG analyst David Larsen reiterates Health Catalyst (NASDAQ:HCAT) from Neutral to Neutral.
Canaccord Genuity analyst Richard Close maintains Health Catalyst (NASDAQ:HCAT) with a Buy and lowers the price target from ...
Evercore ISI Group analyst Elizabeth Anderson maintains Health Catalyst (NASDAQ:HCAT) with a In-Line and raises the price ta...
